SynthesisBreast (Edinburgh, Scotland)2021

Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials.

Hong-Fei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.